Coherus Oncology Inc share price logo

Coherus Oncology Inc Share Price

NASDAQ: CHRS

$1.74

-0.02

(-1.14%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app

Coherus Oncology Inc Stock Performance

as on April 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.72
    $1.77
    downward going graph

    1.15%

    Downside

    1.72%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.71
    $2.62
    downward going graph

    59.20%

    Downside

    50.33%

    Upside

    downward going graph

Coherus Oncology Inc share price movements today

Previous Close
$1.76
Open
$1.76
Volume
1.3M
Day's Low - High
$1.72 - $1.77
52 Week Low - High
$0.71 - $2.62

Coherus Oncology Inc Historical Returns

1 Month Return
-0.56 %
3 Month Return
-14.56 %
1 Year Return
+ 70.87 %
3 Year Return
-77.38 %
5 Year Return
-88.18 %

Coherus Oncology Inc Stock Fundamentals & Key Indicators

Check Coherus Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Coherus Oncology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Coherus Oncology Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$--88.18%NA0.00%
BUY$-129.51%NA0.00%
BUY$-99.68%NA0.00%
NA$-NANA0.00%
BUY$-56.77%NA0.00%

Stock Returns calculator for Coherus Oncology Inc Stock including INR - Dollar returns

The Coherus Oncology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Coherus Oncology Inc investment value today

Current value as on today

₹1,86,412

Returns

₹86,412

(+86.41%)

Returns from Coherus Oncology Inc Stock

₹68,932 (+68.93%)

Dollar Impact

₹17,480 (+17.48%)

Analyst Recommendation on Coherus Oncology Inc Stock

Based on 16 analysts

BUY

81.25%

Buy

18.75%

Hold

0.00%

Sell

Based on 16 analysts, 81.25% of analysts recommend a 'BUY' rating for Coherus Oncology Inc. Average target price of $6.75

Coherus Oncology Inc Share Price Target

Get share price movements and forecasts by analysts on Coherus Oncology Inc.

What analysts predicted

74.22%UPSIDE

Target Price

$6.75

Current Price

$1.74

Analyzed by

16 Analysts

Target

$6.75

Coherus Oncology Inc target price $6.75, a slight upside of 74.22% compared to current price of $1.74. According to 16 analysts rating.

Coherus Oncology Inc Stock’s Investor Sentiment and Interest

Search interest for Coherus Oncology Inc Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:5% versus previous 30 day period

Coherus Oncology Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
74
91
2
64
70
54
7
10
11
12
Gross Profit
41
6
0
35
50
20
4
6
7
8
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-39
-79
102
-12
-10
-50
-56
297
-35
-37
Net Profit Margin
-53.16%
-87.03%
4457.32%
-19.88%
-15.19%
-93.63%
-744.43%
2903.91%
-307.07%
-295.29%

Coherus Oncology Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
190
1
1
356
475
326
211
257
266
42
Gross Profit
-64
-158
-1
338
438
268
140
98
149
28
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-127
-238
-209
89
132
-287
-291
-237
28
-170
Net Profit Margin
-66.98%
-15306.56%
-13453.66%
25.23%
27.79%
-87.92%
-138.24%
-92.48%
10.68%
-403.80%

Global Institutional Holdings in Coherus Oncology Inc

Funds
Holdings
BlackRock Inc
6.98%
Geode Capital Management, LLC
1.83%
Panagora Asset Management Inc
1.08%
Charles Schwab Investment Management Inc
0.62%
Vanguard Group Inc
6.69%

Insights on Coherus Oncology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CHRS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 7.59M → 12.74M (in $), with an average increase of 15.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Coherus Oncology Inc has experienced a drawdown of -77.4%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 74.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 297.76M → -37.64M (in $), with an average decrease of 58.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CHRS stock has moved down by -11.1%

About Coherus Oncology Inc

Coherus Oncology, Inc., formerly Coherus BioSciences, Inc., is a fully integrated commercial-stage oncology company with an approved PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. LOQTORZI (toripalimab-tpzi) is its immuno-oncology franchise. LOQTORZI is the FDA-approved treatment indicated in combination with chemotherapy for recurrent or metastatic nasopharyngeal carcinoma (NPC) and is also in development for the treatment of additional tumor types. Its CHS-114 pipeline is a highly selective cytolytic CCR8 antibody that specifically binds and preferentially depletes CCR8+ tumor regulatory T cells (Tregs) with no off-target binding. Its Casdozokitug pipeline is a first-in-class, clinical-stage IL-27 antagonist, with demonstrated monotherapy activity in treatment-refractory NSCLC and clear cell renal cell carcinoma (ccRCC) and combination activity in hepatocellular carcinoma (HCC).
OrganisationCoherus Oncology Inc
IndustryHealth Care
E-voting on sharesClick here to vote

FAQs

What is Coherus Oncology Inc share price today?

Coherus Oncology Inc share price today is $1.74 as on at the close of the market. Coherus Oncology Inc share today touched a day high of $1.77 and a low of $1.72.

What is the 52 week high and 52 week low for Coherus Oncology Inc share?

Coherus Oncology Inc share touched a 52 week high of $2.62 on and a 52 week low of $0.71 on . Coherus Oncology Inc stock price today i.e. is closed at $1.74,which is 33.48% down from its 52 week high and 145.07% up from its 52 week low.

How to invest in Coherus Oncology Inc Stock (CHRS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Coherus Oncology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Coherus Oncology Inc Shares that will get you 0.8621 shares as per Coherus Oncology Inc share price of $1.74 per share as on April 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Coherus Oncology Inc Stock (CHRS) from India?

Indian investors can start investing in Coherus Oncology Inc (CHRS) shares with as little as ₹94.22 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.20 in Coherus Oncology Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Coherus Oncology Inc share’s latest price of $1.74 as on April 25, 2026 at 1:29 am IST, you will get 5.7471 shares of Coherus Oncology Inc. Learn more about fractional shares .

What are the returns that Coherus Oncology Inc has given to Indian investors in the last 5 years?

Coherus Oncology Inc stock has given -88.18% share price returns and 25.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?